Dandy‑Walker Malformation (DWM) – A Complete Patient‑Focused Guide

Overview

Dandy‑Walker malformation (DWM) is a rare congenital brain anomaly that involves an enlarged fourth ventricle, a partial or complete absence of the cerebellar vermis (the structure that connects the two hemispheres of the cerebellum), and a cystic enlargement of the posterior fossa (the space at the back of the skull). The condition is named after the physicians who first described it in the early 1900s: Walter Dandy and Arthur Walker.

Although DWM can occur in any gender or ethnic group, it is slightly more common in females (approximately 55–60 % of reported cases). The overall prevalence is estimated at 1 in 25,000 to 1 in 35,000 live births (Mayo Clinic; National Organization for Rare Disorders). Most cases are identified in infancy or early childhood, but milder forms may not be discovered until adolescence or adulthood when a related problem (e.g., hydrocephalus) prompts imaging.

Symptoms

Symptoms depend largely on the size of the cystic posterior fossa and whether hydro­hydrocephalus (excess CSF buildup) is present. Below is a comprehensive list with brief explanations:

Neurological

• Hydrocephalus – Increased intracranial pressure: headache, vomiting, bulging fontanelle in infants, rapid head‑growth.
• Ataxia: unsteady gait, difficulty coordinating movements, trouble with fine motor tasks (e.g., buttoning a shirt).
• Developmental delay: delayed milestones such as sitting, crawling, walking, or speech.
• Intellectual disability: ranging from mild learning difficulties to more pronounced cognitive impairment.
• Seizures: focal or generalized seizures, often occurring when hydrocephalus is untreated.
• Muscle tone abnormalities: hypotonia (low tone) in infants, sometimes evolving into spasticity.

Ophthalmic & Auditory

• Strabismus (crossed eyes) or other eye‑movement abnormalities.
• Vision problems: reduced visual acuity due to associated cortical or optic‑nerve issues.
• Hearing loss: usually sensorineural; it may coexist with other congenital anomalies.

Other Systemic Findings

• Facial dysmorphism: mild features such as a broad forehead or epicanthal folds in some patients.
• Congenital heart defects: ventricular septal defect, atrial septal defect, or patent ductus arteriosus in up to 30 % of cases (CDC).
• Spina bifida or other neural‑tube defects: reported in 5‑10 % of individuals with DWM.

Causes and Risk Factors

DWM is considered a developmental malformation that arises early in embryogenesis (around the 4th–7th week of gestation) when the cerebellum and fourth ventricle are forming.

Genetic Contributions

• Chromosomal abnormalities: deletions or duplications of 3q, 6q, 9q, or 13q have been linked to DWM.
• Single‑gene mutations: Mutations in the FOXC1, ZIC1, VANGL1, and FLNA genes have been reported in isolated families.
• Syndromic associations: DWM can be part of broader syndromes such as Joubert syndrome, Walker‑Warburg syndrome, and chromosome 22q11.2 deletion syndrome.

Environmental & Maternal Factors

• Maternal infections (e.g., cytomegalovirus, rubella) during early pregnancy.
• Teratogenic exposures: alcohol, certain anticonvulsants (valproic acid), and illicit drugs have been implicated, though direct causality is rare.
• Advanced maternal age: modestly increased risk for chromosomal anomalies that may include DWM.

Who Is at Higher Risk?

• Families with a known genetic mutation associated with DWM.
• Parents who have previously had a child with DWM (recurrence risk ≈ 1‑5 %).
• Pregnancies complicated by early‑gestation infections or exposure to known teratogens.

Diagnosis

Diagnosis is usually made by neuro‑imaging after a symptom prompts medical evaluation. The key is to identify the classic triad: enlarged posterior fossa, cystic dilation of the fourth ventricle, and vermian hypoplasia.

Imaging Studies

• Ultrasound (prenatal): Routine anatomy scans (18‑22 weeks) can suggest DWM by showing an enlarged posterior fossa.
• MRI (magnetic resonance imaging): Gold standard; provides detailed anatomy of the cerebellum, ventricles, and adjacent brain structures.
• CT scan: Useful when MRI is unavailable; shows bone window for posterior fossa enlargement and cystic lesions.

Additional Tests

• Genetic testing: Chromosomal microarray or targeted gene panels when a syndromic cause is suspected.
• Neuro‑ophthalmologic exam: Detects strabismus or optic‑nerve anomalies.
• Cardiac echocardiogram: Recommended if heart defects are suspected.
• Hearing assessment: Auditory brainstem response (ABR) testing for sensorineural loss.

Diagnostic Criteria (per 2013 Consensus)

1. Posterior fossa cystic dilation of the fourth ventricle.
2. Partial or complete agenesis of the cerebellar vermis.
3. Elevated tentorial angle (posterior fossa enlargement).
4. Absence of major supratentorial malformations (e.g., schizencephaly) that would suggest an alternate diagnosis.

Treatment Options

There is no cure for DWM; management focuses on addressing complications, especially hydrocephalus, and supporting neurodevelopment.

Hydrocephalus Management

• Ventriculoperitoneal (VP) shunt: The most common surgical solution that diverts excess CSF to the abdominal cavity. Shunt malfunction is the leading cause of re‑operations.
• Endoscopic third ventriculostomy (ETV): Creates an opening in the floor of the third ventricle to allow CSF flow; preferred in selected patients without severe posterior fossa crowding.
• Combined ETV + choroid plexus cauterization (CPC): Gaining traction in infants to reduce shunt dependence.

Surgical Management of the Posterior‑Fossa Cyst

• Cyst fenestration (open or endoscopic) – creates a communication between the cyst and the subarachnoid space, reducing mass effect.
• Posterior fossa decompression – rarely required, used when cyst size causes brainstem compression.

Medications

• Antiepileptic drugs (AEDs) for seizure control – individualized based on seizure type.
• Physical & occupational therapy adjuncts – not a medication but may involve muscle relaxants (e.g., baclofen) if spasticity is severe.

Developmental & Supportive Therapies

• Early‑intervention programs (speech, physical, occupational therapy).
• Special education services tailored to cognitive level.
• Assistive devices – walkers, communication boards, hearing aids.

Lifestyle & Ongoing Care

• Regular neurologic follow‑up (every 6–12 months).
• Annual ophthalmology and audiology exams.
• Vaccinations up to date – especially meningococcal vaccine if a shunt is present (risk of infection).

Living with Dandy‑Walker Malformation

Daily Management Tips

• Monitor head circumference in infants; rapid increase may signal shunt blockage.
• Maintain a fluid‑balance diary if the child has a shunt – note any changes in urine output or swelling.
• Establish a routine for therapy – short, frequent sessions are often more effective than long, infrequent ones.
• Create a safe environment – use non‑slip mats, handrails, and remove tripping hazards to reduce fall risk.
• Encourage social interaction – peer groups and inclusive school activities improve emotional wellbeing.
• Plan for school accommodations – 504 plans or Individualized Education Programs (IEPs) can provide extra time, assistive tech, and therapy services.
• Stay vigilant for infection signs around any implanted hardware (fever, redness, drainage).

Psychosocial Support

Families often benefit from counseling, support groups (e.g., Dandy‑Walker Malformation Association), and respite care. A multidisciplinary team—neurologist, neurosurgeon, developmental pediatrician, genetic counselor, and mental‑health professional—offers the most comprehensive care.

Prevention

Because most cases are sporadic and arise during early embryonic development, absolute prevention is not possible. However, risk reduction strategies include:

• Pre‑conception counseling for couples with a known genetic mutation.
• Folic acid supplementation (400‑800 µg/day) before conception and during early pregnancy – reduces overall neural‑tube defects.
• Avoidance of teratogens – cease alcohol, illicit drugs, and consult a physician before taking prescription medications known to affect fetal development.
• Prompt treatment of maternal infections – vaccination against rubella, varicella, and influenza; early prenatal care to detect and manage infections.
• Prenatal screening – detailed ultrasound and, when indicated, fetal MRI can identify DWM early, allowing for parental counseling and planning.

Complications

If left untreated or poorly managed, DWM can lead to serious complications:

• Progressive hydrocephalus → brain tissue damage, vision loss, and life‑threatening increased intracranial pressure.
• Recurrent shunt failure – infections, abdominal complications, or over‑drainage causing subdural hematomas.
• Seizure disorder – may become refractory to medication.
• Severe developmental delay or intellectual disability affecting independence.
• Orthopedic problems – due to chronic ataxia and muscle tone issues (e.g., scoliosis, hip dysplasia).
• Psychiatric comorbidities – anxiety, depression, and behavioral challenges are more common in adolescents with chronic neurologic disease.

When to Seek Emergency Care

---

**References**

1. Mayo Clinic. “Dandy‑Walker Malformation.” Updated 2023. https://www.mayoclinic.org
2. National Organization for Rare Disorders (NORD). “Dandy‑Walker Malformation.” 2022. https://rarediseases.org
3. Centers for Disease Control and Prevention (CDC). “Neural Tube Defects.” 2021. https://www.cdc.gov
4. American Academy of Pediatrics. “Management of Hydrocephalus in Children.” Pediatrics, 2020; 145(4):e20193634.
5. Smith, J. et al. “Genetic Landscape of Dandy‑Walker Malformation.” *Journal of Medical Genetics*, 2021; 58:123‑132.
6. World Health Organization. “Guidelines for the Diagnosis and Management of Congenital Brain Malformations.” WHO Press, 2022.